Arkolith/Insider Trading/CMMB/Form 4

Marvin Donald

Executive VP, CFO & COOChemomab Therapeutics Ltd. (CMMB) · full profile →Form 4 · filed Mar 21, 2022
Net Buying
Open-Market Buys
$5K
Open-Market Sells
$0
Net Open-Market Flow
$5K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2022Buy(P)250$3.90$9751K
Mar 14, 2022Buy(P)250$4.10$1K1K
Mar 14, 2022Buy(P)250$4.20$1K2K
Mar 14, 2022Buy(P)250$4.00$1K250
Mar 14, 2022Buy(P)250$3.98$995500

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 8, 2021Grant(A)197K—$0197K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001178913-22-001179) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Chemomab Therapeutics Ltd.

Build

Ask your agent about CMMB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001178913-22-001179"
Ask your agent
Use Arkolith to summarize insider buying and selling at Chemomab Therapeutics Ltd.
over the last 90 days and cite the filings.